Rodger P. McEver
33Patents
14h-index
16Co-inventors
78Inventor score
Filing activity: Mar 8, 1989 → Nov 27, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6124267A | O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1 | Chemistry; Metallurgy | 63 | Expired |
| US5026537A | Methods for imaging atherosclerotic plaque | Emerging Cross-Sectional Technologies | 54 | Expired |
| US6309639A | Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand | Human Necessities | 52 | Expired |
| US5464778A | Glycoprotein ligand for P-selectin and methods of use thereof | Human Necessities | 51 | Expired |
| US5880091A | Glycoprotein ligand for P-selectin and methods of use thereof | Human Necessities | 51 | Expired |
| US5198424A | Functionally active selectin-derived peptides | Human Necessities | 50 | Expired |
| US6177547A | Antibodies to P-selectin glycoprotein ligand | Human Necessities | 48 | Expired |
| US6111065A | Peptide inhibitors of inflammation mediated by selectins | Human Necessities | 42 | Expired |
| US6528487B1 | Peptide inhibitors of inflammation mediated by selectins | Human Necessities | 41 | Expired |
| US5378464A | Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140 | Human Necessities | 33 | Expired |
| US6569998B2 | Synthetic glycosulfopeptides and methods of synthesis thereof | Human Necessities | 25 | Expired |
| US5852175A | P-selectin glycoprotein ligand blocking antibodies | Human Necessities | 23 | Expired |
| US5929036A | Ligand or GMP-140 selectin and methods of use thereof | Human Necessities | 20 | Expired |
| US6667036B2 | Methods of treatment using antibodies to P-selectin glycoprotein ligand | Human Necessities | 18 | Expired |
| US5767241A | Soluble form of GMP-140 | Human Necessities | 14 | Expired |
| US7776591B2 | Hematopoietic stem cells treated by in vitro fucosylation and methods of use | Human Necessities | 12 | Active |
| US8633021B2 | Stem cells treated by in vitro fucosylation and methods of use | Human Necessities | 9 | Active |
| US7332334B2 | Hematopoietic stem cells treated by in vitro fucosylation and methods of use | Human Necessities | 8 | Expired |
| US6506382B2 | Method for inhibiting reperfusion injury using antibodies to P-selectin glycoprotein ligand | Human Necessities | 8 | Expired |
| US8377440B2 | Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases | Chemistry; Metallurgy | 6 | Active |
| US7223845B2 | Synthetic glycosulfopeptides and methods of synthesis thereof | Chemistry; Metallurgy | 5 | Expired |
| US8084255B2 | Stem cells treated by in vitro fucosylation and methods of use | Human Necessities | 4 | Active |
| US6593459B1 | Synthetic glycosulfopeptides and methods of synthesis thereof | Human Necessities | 4 | Expired |
| US7189828B2 | Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof | Chemistry; Metallurgy | 3 | Expired |
| US5919637A | Method for identifying reduced binding between GMP-140 and GMP-140 ligand | Human Necessities | 3 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.